CorMedix Inc (NASDAQ: CRMD) on Monday, plunged -4.00% from the previous trading day, before settling in for the closing price of $9.99. Within the past 52 weeks, CRMD’s price has moved between $2.57 and $13.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -47.11%. The company achieved an average annual earnings per share of 45.05%. With a float of $59.73 million, this company’s outstanding shares have now reached $60.68 million.
The extent of productivity of a business whose workforce counts for 82 workers is very important to gauge. In terms of profitability, gross margin is 94.0%, operating margin of -29.11%, and the pretax margin is -24.63%.
CorMedix Inc (CRMD) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of CorMedix Inc is 1.56%, while institutional ownership is 30.62%. The most recent insider transaction that took place on Mar 13 ’24, was worth 50,718. In this transaction Chief Executive Officer of this company bought 13,561 shares at a rate of $3.74, taking the stock ownership to the 352,839 shares. Before that another transaction happened on Dec 14 ’23, when Company’s Director bought 3,000 for $3.45, making the entire transaction worth $10,350. This insider now owns 12,250 shares in total.
CorMedix Inc (CRMD) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.26 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.2) by -0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 45.05% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
CorMedix Inc (CRMD) is currently performing well based on its current performance indicators. A quick ratio of 3.60 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 47.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.36 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
The latest stats from [CorMedix Inc, CRMD] show that its last 5-days average volume of 2.35 million was superior to 0.71 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 9.32%. Additionally, its Average True Range was 0.83.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 58.40%, which indicates a significant increase from 4.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 121.70% in the past 14 days, which was higher than the 82.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.62, while its 200-day Moving Average is $5.47. Now, the first resistance to watch is $10.26. This is followed by the second major resistance level at $10.93. The third major resistance level sits at $11.36. If the price goes on to break the first support level at $9.16, it is likely to go to the next support level at $8.73. The third support level lies at $8.06 if the price breaches the second support level.
CorMedix Inc (NASDAQ: CRMD) Key Stats
Market capitalization of the company is 578.14 million based on 60,677K outstanding shares. Right now, sales total 0 K and income totals -46,340 K. The company made 810 K in profit during its latest quarter, and -14,150 K in sales during its previous quarter.
